What Is Cardarine (GW-501516)? A Preclinical Research Overview

By Your Health Magazine

Your Health Magazine

. http://yourhealthmagazine.net

More Health News & Research Articles

What Is Cardarine (GW-501516)? A Preclinical Research Overview

GW-501516 is a synthetic chemical research compound. It was originally developed in the 1990s as a potential treatment for metabolic and cardiovascular diseases. It is not approved for human use. GW-501516 was discovered through a research collaboration between GlaxoSmithKline and Ligand Pharmaceuticals. Its pharmaceutical development was terminated after carcinogenicity signals appeared in long-term animal studies. However, it is still considered a drug candidate. All data remains experimental, and the risk profile is significant.

Disclaimer: Cardarine GW-501516 is a research compound not approved by the U.S. Food and Drug Administration (FDA) for human or veterinary use. It is not intended to diagnose, treat, cure, or prevent any disease. This product is strictly for laboratory research purposes only.

There are not many research compounds that carry two opposite stories at the same time. GW-501516 is one of them.

On one side, there is a mechanism that has attracted genuine preclinical research interest. This is because the compound may interact with a receptor involved in how cells decide which fuel to burn. On the other side, there is a carcinogenicity signal that emerged in long-term animal studies. This caused GlaxoSmithKline to shut down all development in 2007.

Neither story exists without the other. If you are researching this compound, you need both.

This is a research context overview and not a product guide. It is not a recommendation. It is just a summary of what science currently shows.

What Exactly Is GW-501516?

GW-501516 is also known as Cardarine. It is a synthetic compound that acts on a receptor called PPARδ. It was developed originally as part of research into metabolic conditions.

GW-501516 is not a SARM. It gets mixed up with SARMs regularly online. However, that is scientifically wrong. SARMs interact with androgen receptors. GW-501516 does not. It works through a completely different pathway.

The FDA does not approve it. It is not approved for human or veterinary use anywhere in the world.

What Is PPARδ and Why Do Researchers Investigate It?

PPARδ is a protein found inside cells. This is specifically true in the cell nucleus. Think of it as a switch. When something binds to it, it turns certain genes on or off. In this case, the genes it may affect are ones involved in how the cell handles fat and energy.

PPARδ is concentrated in skeletal muscle specifically. Its levels are approximately 10 times higher than PPARα and 50 times higher than PPARγ. That is one reason it has been studied in the context of muscle metabolism and fat processing (both in preclinical laboratory settings).

The selective activation of this receptor is the reason why it has been used in laboratory settings to investigate what happens when PPARδ is switched on.

What Are Preclinical Animal Studies Investigating with GW-501516?

All of the following findings are from in vitro or animal model studies only. None of this represents established human pharmacology.

How Cells May Process Fat Differently

One area researchers have investigated is whether GW-501516 changes how skeletal muscle cells handle fat versus glucose as an energy source.

In cell culture models, GW-501516 has been observed to upregulate genes involved in transporting and breaking down fatty acids. These include FABP3, CPT1, and PDK4. Simply put, it means that the cells appeared to shift toward using fat rather than sugar for energy.

That said, findings are not consistent across all models. This tells researchers that the effects may depend heavily on which cell type is being studied and under what conditions.

AMPK — The Cell’s Energy Sensor

A second area of investigation involves AMPK. This is a protein sometimes described as the cell’s built-in energy gauge. When energy runs low, AMPK activates to restore balance.

In laboratory studies, GW-501516 was observed to activate AMPK and increase fat transport and processing. Researchers found that both PPARδ and AMPK appeared to be involved in producing these changes.

Gene Expression in Skeletal Muscle

Researchers have also investigated whether GW-501516 changes which genes are active in skeletal muscle cells. This is specifically the case in genes related to breaking down lipids and regulating cellular energy.

In cell-based studies, PPARδ activation by GW-501516 appeared to produce a different gene expression pattern compared to when other PPAR subtypes were activated.

How Mitochondria Choose Their Fuel

Mitochondria are the structures inside cells that produce energy. They can run on either fat or glucose. Researchers have used GW-501516 in preclinical models to investigate whether PPARδ activation affects which fuel source mitochondria prefer.

Studies in isolated rat skeletal muscle observed a dose-dependent increase in fat oxidation alongside a reduction in glucose oxidation in that model system.

What Are the Risks and Limitations of GW-501516 Research?

This section is mandatory reading before working with GW-501516 in any laboratory setting.

Handling Precautions:

GW-501516 should be handled by trained laboratory personnel only, in a controlled research environment. Use appropriate PPE at all times. Avoid direct skin contact or inhalation of any powder or reconstituted solution. 

Exposure Risks: 

GW-501516 is a synthetic PPARδ agonist research compound. No human safety data exists beyond very limited early-phase studies conducted prior to pharmaceutical termination. The World Anti-Doping Agency (WADA) has issued formal health risk warnings and added GW-501516 to its prohibited list. The Australian Therapeutic Goods Administration has classified it as a poisonous substance under Schedule 10. The FDA has issued warning letters to companies marketing GW-501516 products.

Storage: Store GW-501516 at −20°C in a dry, dark environment. Protect from light, heat, and moisture at all times. Keep sealed until use.

Conclusion

GW-501516 sits at an uncomfortable intersection of scientific interest and unresolved risk. Preclinical studies have investigated its potential to influence fat oxidation pathways, AMPK signaling, gene expression in skeletal muscle, and mitochondrial fuel selection (all in controlled laboratory settings). PPARδ remains an active subject of metabolic research, and GW-501516 has been used in in vitro and short-duration animal studies to probe how this receptor may work.

But its pharmaceutical development was terminated (not paused) because of what long-term animal data showed. That decision has never been reversed. No regulatory body has approved it. No clinical programme is pursuing it. Data remains limited. Risk profile is unresolved.

Frequently Asked Questions

What is GW-501516 investigated for in preclinical research?

GW-501516 has been used in animal and cell-based studies to investigate PPARδ-mediated pathways, specifically fatty acid oxidation, AMPK signaling, mitochondrial fuel selection, and lipid catabolism gene expression in skeletal muscle model systems. It is not approved for human use and is available strictly for laboratory research.

Is GW-501516 a SARM?

No. It is not a selective androgen receptor modulator. SARMs interact with androgen receptors. GW-501516 activates PPARδ, which is a completely different receptor that regulates gene expression related to fat and energy metabolism.

Is it safe to work with GW-501516 in a laboratory?

It carries a significant risk profile. Long-term animal studies produced carcinogenicity signals at multiple organ sites, which ended its pharmaceutical development. It is classified as a poisonous substance in Australia, and WADA has issued formal health risk warnings. 

Is GW-501516 approved for human use anywhere?

No. It is not approved for human or veterinary use by any regulatory authority anywhere in the world. The FDA has issued warning letters to companies marketing it as a supplement or for human use. It is available strictly as a research compound for qualified laboratory use only.

What to Look for in a Supplier when buying research-grade Cardarine GW-501516?

Check that every batch is independently third-party tested for purity and identity, and a Certificate of Analysis is available for each lot. You can try trusted sites like BehemothLabz, where all compounds are sold strictly for preclinical and in vitro research use.

Note: All BehemothLabz products are strictly for LABORATORY AND RESEARCH PURPOSES ONLY. They are not to be used for any human or veterinary purposes.

Disclosure: Sponsored by BehemothLabz. This content is for informational purposes only and does not constitute an endorsement of any product for human use.

References

[1] Tanaka T, et al. Activation of peroxisome proliferator-activated receptor delta induces fatty acid beta-oxidation in skeletal muscle and attenuates metabolic syndrome. Proceedings of the National Academy of Sciences. 2003;100(26):15924–15929. https://pubmed.ncbi.nlm.nih.gov/14676330/[2] Olsen GS, et al. Role of AMP kinase and PPARdelta in the regulation of lipid and glucose metabolism in human skeletal muscle. Journal of Lipid Research. 2008. https://pubmed.ncbi.nlm.nih.gov/17500064/